TrialMelanoma research2016

A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma.

Alexander N Shoushtari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.